Cargando…
Adenosine monophosphate kinase activator α‐lipoic acid: A promising therapeutic agent for metabolic syndrome?
Autor principal: | Lee, In‐Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014959/ https://www.ncbi.nlm.nih.gov/pubmed/24843490 http://dx.doi.org/10.1111/j.2040-1124.2011.00144.x |
Ejemplares similares
-
Adenosine monophosphate–activated protein kinase in diabetic nephropathy
por: Kim, Yaeni, et al.
Publicado: (2016) -
Cereblon contributes to the development of pulmonary fibrosis via inactivation of adenosine monophosphate-activated protein kinase α1
por: Kang, Hyo Jae, et al.
Publicado: (2021) -
Roles of adenosine monophosphate-activated protein kinase (AMPK) in the kidney
por: Zhu, Na, et al.
Publicado: (2022) -
Ribavirin suppresses hepatic lipogenesis through inosine monophosphate dehydrogenase inhibition: Involvement of adenosine monophosphate‐activated protein kinase‐related kinases and retinoid X receptor α
por: Satoh, Shinya, et al.
Publicado: (2017) -
Diabetic conditions modulate the adenosine monophosphate-activated protein kinase of podocytes
por: Ha, Tae-Sun, et al.
Publicado: (2014)